FGF23 and hypophosphatemia: Both XLH patients and Hyp mice are characterized by hypophosphatemia, impaired bone mineralization, inappropriately low serum vitamin D hormone (1,25(OH)2D3), and increased circulating intact fibroblast growth factor-23 (FGF23) [9–11].